Shasun Pharma bets big on formulations in regulated markets
8th June 2014
Looking at setting up a manufacturing facility for formulations, expansion in API capacity.
Shasun Pharmaceuticals is focusing on formulations manufacturing and marketing in the regulated markets, as part of its plan to become an integrated pharmaceutical company. The company is expecting the share of formulations to grow from current 15% of its total revenue to 40% by 2016-17.
It is currently targeting that its transformation towards becoming an integrated global pharma company with focus on the regulated market, to complete in next two years. The company is planning to set up its marketing subsidiary in US.
Read more at source article: www.business-standard.com